Related Experiment Videos
Inspiratory stridor in elite athletes
Kenneth W Rundell1, Barry A Spiering
1United States Olympic Committee, Lake Placid, NY, USA.
Chest
|February 11, 2003
Summary
Inspiratory stridor (IS) affects 5% of athletes and is often misdiagnosed as exercise-induced bronchospasm (EIB). Spirometry and lack of beta2-agonist response help differentiate IS from EIB.
Area of Science:
- Sports Medicine
- Pulmonary Medicine
- Diagnostic Medicine
Background:
- Exercise-induced bronchospasm (EIB) diagnosis often relies on subjective symptoms, lacking objective spirometric confirmation.
- Inspiratory stridor (IS), a vocal cord dysfunction (VCD) symptom, is frequently misidentified as EIB wheeze in athletes.
- Athletes with exercise-induced IS that resolves post-activity may have VCD, not EIB.
Purpose of the Study:
- To determine the prevalence of inspiratory stridor (IS) in elite athletes.
- To investigate the relationship between IS and exercise-induced bronchospasm (EIB).
- To differentiate IS from EIB using spirometric and pharmacological responses.
Main Methods:
- 370 elite athletes underwent spirometry pre- and post-exercise challenge in cold, dry conditions.
- Exercise-induced bronchospasm (EIB) was defined as a ≥10% postexercise fall in FEV1.
- Athletes were monitored for inspiratory stridor (IS) during exercise; 78.4% had multiple testing sessions.
Main Results:
- EIB was diagnosed in 30% of athletes; IS was observed in 5.1% and resolved post-exercise.
- 53% of IS-positive athletes also had EIB; beta2-agonist treatment failed to resolve IS in most cases.
- Postexercise FEF50/FIF50 ratio > 1.5 was more frequent in IS-positive athletes; IS+/EIB- athletes showed greater FVC fall.
Conclusions:
- Inspiratory stridor (IS) affects 5% of elite athletes and is frequently misdiagnosed as EIB.
- EIB comorbidity is present in 53% of IS-positive athletes.
- Postexercise spirometry and lack of beta2-agonist response aid in distinguishing IS from EIB.